Log In
Print
BCIQ
Print
Print this Print this
 

AG-348

  Manage Alerts
Collapse Summary General Information
Company Agios Pharmaceuticals Inc.
DescriptionOral small molecule activator of pyruvate kinase R
Molecular Target Pyruvate kinase R
Mechanism of ActionPyruvate kinase R activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Metabolic (unspecified)
Indication DetailsTreat pyruvate kinase deficiency
Regulatory Designation U.S. - Orphan Drug (Treat pyruvate kinase deficiency)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today